BioCentury
ARTICLE | Clinical News

Anthrasil anthrax immune globulin IV regulatory update

March 30, 2015 7:00 AM UTC

FDA approved a BLA from Emergent for Anthrasil anthrax immune globulin IV (AIGIV) to treat inhalational anthrax in combination with antibacterial drugs. The approval triggered a $7 million payment to...